Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

Why Ontario parents could soon be paying more for prescription drugs

22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...

Read more →

Where is the champion for Pharmacare?

20 March 2019 - With the possible exception of a few drug company executives, Canadians overwhelmingly support universal pharmacare — ...

Read more →

National drug agency touted as building block of Pharmacare plan

19 March 2019 - The Trudeau Liberals’ new budget promises a new agency to buy drugs in bulk and cut ...

Read more →

Roche and the pan-Canadian Pharmaceutical Alliance complete negotiations for multiple sclerosis treatment, Ocrevus (ocrelizumab), for both RRMS and PPMS

19 March 2019 - Roche Canada today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for a ...

Read more →

Canada to create national drug agency to help cut cost of medicines

20 March 2019 - Canada will create a national drug agency to help cut the cost of prescription medications as part ...

Read more →

The impact of pharmaceutical rebates on patients’ drug expenditures

18 March 2019 - The drug-pricing landscape in Canada is complex, with 4 different agencies and each provincial, territorial and federal ...

Read more →

The Liberals’ plan for Pharmacare? We’re still waiting

14 March 2019 - The Trudeau government is edging closer to announcing its proposals for some kind of national drug ...

Read more →

Trudeau Government signals it will soon announce Pharmacare plan

7 March 2019 - Morneau says drug program ‘unfinished business’ of health care. ...

Read more →

Canada should create new drug agency and list of medications available to everyone, council says

6 March 2019 - Canada should tiptoe in the direction of national pharmacare by creating a new drug agency and ...

Read more →

Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage

5 March 2019 - As the interplay between the pharmaceutical industry and patient advocacy groups undergoes stepped-up scrutiny, a new ...

Read more →

Evaluating Canadians’ values for drug coverage decision making

2 March 2019 - Decision makers are facing growing challenges in prioritising drugs for reimbursement because of soaring drug costs and ...

Read more →

Panel backs provincial funding for expensive drug to treat rare disease. But only for children.

4 March 2019 - Provincial governments should expand public funding for one of the world’s most expensive medications to cover ...

Read more →

Biogen responds to CADTH’s updated recommendation regarding coverage for Spinraza

1 March 2019 - CADTH has expanded their recommendations for public reimbursement for SMA patients. ...

Read more →

Drug prices aren’t a big problem, but Ottawa’s trying to control the market anyway

28 February 2019 - New policies will reduce access to new medicines for patients and impose massive new costs on taxpayers. ...

Read more →